Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Auto Control Medical Partners with STI’s innoviCares Program to Lower Cost of Home Diabetes Testing in Canada


Posted on: 06 Sep 17

MISSISSAUGA, Ontario, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Auto Control Medical, a division of A&D Canada and leading distributor of home diagnostic devices and supplies, today announced that it is teaming up with STI to lower diabetes healthcare costs for Canadians.

With more than 1.5 million Canadian members to date, the STI innoviCares card is a free program designed to help consumers save money on name brand prescription drugs and devices. With the innoviCares card, Canadians will now be eligible to save up to $10 of their out-of-pocket costs whenever they make a purchase of test strips in their local pharmacy. This savings is only available for glucose strips used by the GE200 and DARIO meters

For people managing diabetes, this represents significant cost savings: a standard three tests per day with typical out-of-pocket costs could amount to saving more than $150 on an annual basis – an offer not available on the vast majority of testing strips in the marketplace.

The innoviCares card provides savings on GE200 and DARIO blood glucose test strips, the two testing platforms offered by Auto Control Medical:

  1. The GE-branded GE200 is an easy-to-use monitor that features the largest screen on the market as well as large, tactile test strips that are generally priced below other brands and well-recognized for their accuracy.
     
  2. The DARIO diabetes management system is an all-in-one device which allows the user to test right on their smart device and log all results automatically. Consumers can then easily share results with family members and health care professionals. Use of a smart device also eliminates the need to carry the usual case with testing supplies.  

“We are pleased to announce the addition of our glucose strips to the innoviCares program, and offer Canadians this unique savings package on our blood glucose monitors,” said Robert Burgy, General Manager of Auto Control Medical said in a joint statement with STI. “Effective immediately, the innoviCares card will provide financial assistance to customers seeking the DARIO and GE Blood Glucose Test Strips when they present their card with a prescription at their pharmacy.”

Available throughout all provinces (except Québec) and territories, any Canadian is eligible for the innoviCares card program. The GE 200 is now available at Walmart pharmacies, in addition to London Drugs, Rexall, Safeway and other participating pharmacies. The DARIO glucose meter is stocked at London Drugs, Lawtons, Safeway as well as other participating pharmacies.

About Auto Control Medical
Auto Control Medical is a division of A&D Canada, Inc., a subsidiary of A&D Company. Auto Control Medical is one of the premier distributors of hypertension, diabetes and respiratory products in Canada. Auto Control Medical has developed an extensive customer network in its more than 27 years of service, and distributes healthcare products through pharmacies, home care stores and other channels throughout Canada. The development of a strong focus on self-monitoring devices plays an important role in Auto Control Medical’s success. The introduction of new items in Auto Control’s product line involves considerable groundwork. Auto Control’s reputation for product knowledge, training sessions and effective communication all serve to help bring new innovative products to market quickly and effectively.

For more information, please visit www.autocontrol.com.

About innoviCares
InnoviCares is Canada's largest free prescription savings card, covering more than 100 brand-name medications and healthcare products from 23 Canadian pharmaceutical manufacturers.

The innoviCares card works like any drug insurance card at the pharmacy, instantly paying a portion of the cost of participating products. Funded by participating pharmaceutical manufacturers, innoviCares is easy to use and available to all Canadians at no cost.

InnoviCares delivers choice, is easy to use, and supports Canadians to achieve better health outcomes. We're empowering Canadians to take control of their health.

For more information, please visit: www.innoviCares.ca/en.

 

GlobeNewswire
globenewswire.com

Last updated on: 06/09/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.